Approaches to Algorithm Development for the Estimation of Lines of Therapy in Oncology Using Real-World Data
Author(s)
Discussion Leader: Chi Nguyen, PhD, HealthCore, Inc., Wilmington, DE, USA
Discussants: Bal Nepal, PhD, Health Economics and Outcomes Research, HealthCore, Inc., Bear, DE, USA; Lisa M Hess, PhD, GPORWE, Eli Lilly and Company, Indianapolis, IN, USA; Julia F. Slejko, PhD, Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD, USA
Presentation Documents
PURPOSE: Cancer treatment is complex, involving the sequential use of different treatment regimens as disease progresses. This workshop will discuss the challenges of identifying distinct lines of therapy (LOT) in real-world oncology studies and present best practices to generate reliable LOT algorithms. The workshop will provide practical examples of cancer treatment pattern analysis using retrospective, observational, real-world data (RWD).
DESCRIPTION: The accurate quantification of LOTs is critical for the identification of distinct points of care for comparative research, treatment decision-making at disease progression, and for the accurate evaluation of treatment pathways. There is no standard method to define LOTs for solid or hematologic malignancies, in part due to disease heterogeneity and the rapid pace of treatment innovation.
The learning objectives of this workshop are:- To understand the importance of accurately defining LOTs
- To identify the necessary components of a LOT algorithm
- To distinguish the variables that can impact algorithm development from different databases
- To assess the differences in algorithms by tumor type
- To critically evaluate research using LOT algorithms
- To share a case study using administrative claims and clinical data
- LOT background and key considerations (Chi Nguyen, 10 minutes);
- Step-by-step best practices to develop and validate LOT algorithms (Lisa Hess, 15 minutes)
- Case study example of LOT analysis using large administrative claims data integrated with clinical data (Bal Nepal, 15 minutes).
- Challenges with data sources; algorithms for solid vs. hematologic malignancies (Julia Slejko, 10 minutes).
Conference/Value in Health Info
Code
224